In crisis, the nucleus calls antioxidant enzymes to the rescue. This indicates metabolic activity, which would be a profound paradigm shift with implications for cancer research.
RECERCA
24
Apr
2023
Differentiation landscape of acute myeloid leukemia charted with new tool
The findings pave the way for the development of new techniques to predict how AML patients will respond to chemotherapy.
RECERCA
06
Apr
2023
Controversial beta cell origin theory challenged by diabetes experts
Dr. Jorge Ferrer challenges the view that adult mice form new beta cells which arise from pancreatic duct cells
RECERCA
06
Apr
2023
tRNA biomarkers for cancer diagnosis and prognosis enabled by new method
The new method can lead to earlier detection of diseases and improved patient outcomes
RECERCA
30
Mar
2023
Epigenome mapped in detail across human body
International team of CRG, Harvard, Yale, MIT, CSHL and Johns Hopkins publish personalised epigenomes of four individuals in Cell
RECERCA
07
Mar
2023
Heart toggles between maintenance and energy-boost mode using ribosomes
New mechanism found which can be exploited to prevent or heal damage to the heart
RECERCA
13
Feb
2023
Seasonal and circadian genetic variation charted across the human body
Atlas of circadian and circannual variation reveals therapeutic targets which could benefit from different doses depending on time of day and season
RECERCA
09
Feb
2023
‘Tiny but mighty’ gene fragments are crucial for maintaining blood sugar levels
Microexons constitute new potential therapeutic targets for treating diabetes
RECERCA
19
Jan
2023
‘Living medicine’ created to tackle drug-resistant lung infections
Study showcases synthetic biology's potential in transforming treatment of human disease
RECERCA
28
Dec
2022
Human diabetes risk influenced by genomic regulation of RNA splicing
RNA splicing regulation influences transcription of genes inked to type-1 and type-1 diabetes risk